Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancerC Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
Cancer|January 15, 1995
Sequential chemotherapy and radiotherapy for patients with squamous cell carcinoma of the esophagusE A Le Prise, B C Meunier, P L Etienne, et al.
British Journal of Cancer|October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancerT Conroy, Y Yataghène, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patientsM Ducreux, E Mitry, M Ould-Kaci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative GroupT Conroy, P L Etienne, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survivalT Conroy, P L Etienne, A Adenis, et al.
Neuroendocrinology|August 23, 2008
Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in FranceC Lombard-Bohas, E Mitry, D O'Toole, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2018
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trialJ B Bachet, O Lucidarme, C B Levache, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2018
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancerT Aparicio, O Bouché, E Francois, et al.
Pageof 3